Home > Research > Publications & Outputs > Anti-IL5 therapies for chronic obstructive pulm...

Research

Associated organisational unit

Electronic data

  • Donovan_et_al-2019-Cochrane_Database_of_Systematic_Reviews

    Rights statement: This is the peer reviewed version of the following article:Donovan T, Crossingham I, Milan SJ, Wang R, Bradley P. Anti‐IL5 therapies for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2019, Issue 9. Art. No.: CD013432. DOI: 10.1002/14651858.CD013432 which has been published in final form at https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013432/full This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.

    Final published version, 177 KB, PDF document

    Available under license: CC BY-NC: Creative Commons Attribution-NonCommercial 4.0 International License

Links

Text available via DOI:

View graph of relations

Anti-IL5 therapies for chronic obstructive pulmonary disease

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

Anti-IL5 therapies for chronic obstructive pulmonary disease. / Donovan, T.; Crossingham, I.; Milan, S.J. et al.
In: Cochrane Database of Systematic Reviews, Vol. 2019, No. 9, 20.09.2019.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

Donovan, T, Crossingham, I, Milan, SJ, Wang, R & Bradley, P 2019, 'Anti-IL5 therapies for chronic obstructive pulmonary disease', Cochrane Database of Systematic Reviews, vol. 2019, no. 9. https://doi.org/10.1002/14651858.CD013432

APA

Donovan, T., Crossingham, I., Milan, S. J., Wang, R., & Bradley, P. (2019). Anti-IL5 therapies for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews, 2019(9). https://doi.org/10.1002/14651858.CD013432

Vancouver

Donovan T, Crossingham I, Milan SJ, Wang R, Bradley P. Anti-IL5 therapies for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews. 2019 Sept 20;2019(9). doi: 10.1002/14651858.CD013432

Author

Donovan, T. ; Crossingham, I. ; Milan, S.J. et al. / Anti-IL5 therapies for chronic obstructive pulmonary disease. In: Cochrane Database of Systematic Reviews. 2019 ; Vol. 2019, No. 9.

Bibtex

@article{8f8398ea562c42b0b82d5f7d43b40472,
title = "Anti-IL5 therapies for chronic obstructive pulmonary disease",
abstract = "This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:To assess the efficacy and safety of monoclonal antibody therapies targeting IL‐5 signalling (anti‐IL‐5 or anti‐IL‐5Rα) compared with placebo in the treatment of adults with COPD.",
author = "T. Donovan and I. Crossingham and S.J. Milan and R. Wang and P. Bradley",
note = "This is the peer reviewed version of the following article:Donovan T, Crossingham I, Milan SJ, Wang R, Bradley P. Anti‐IL5 therapies for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2019, Issue 9. Art. No.: CD013432. DOI: 10.1002/14651858.CD013432 which has been published in final form at https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013432/full This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.",
year = "2019",
month = sep,
day = "20",
doi = "10.1002/14651858.CD013432",
language = "English",
volume = "2019",
journal = "Cochrane Database of Systematic Reviews",
issn = "1469-493X",
publisher = "John Wiley and Sons Ltd",
number = "9",

}

RIS

TY - JOUR

T1 - Anti-IL5 therapies for chronic obstructive pulmonary disease

AU - Donovan, T.

AU - Crossingham, I.

AU - Milan, S.J.

AU - Wang, R.

AU - Bradley, P.

N1 - This is the peer reviewed version of the following article:Donovan T, Crossingham I, Milan SJ, Wang R, Bradley P. Anti‐IL5 therapies for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews 2019, Issue 9. Art. No.: CD013432. DOI: 10.1002/14651858.CD013432 which has been published in final form at https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013432/full This article may be used for non-commercial purposes in accordance With Wiley Terms and Conditions for self-archiving.

PY - 2019/9/20

Y1 - 2019/9/20

N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:To assess the efficacy and safety of monoclonal antibody therapies targeting IL‐5 signalling (anti‐IL‐5 or anti‐IL‐5Rα) compared with placebo in the treatment of adults with COPD.

AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:To assess the efficacy and safety of monoclonal antibody therapies targeting IL‐5 signalling (anti‐IL‐5 or anti‐IL‐5Rα) compared with placebo in the treatment of adults with COPD.

U2 - 10.1002/14651858.CD013432

DO - 10.1002/14651858.CD013432

M3 - Journal article

VL - 2019

JO - Cochrane Database of Systematic Reviews

JF - Cochrane Database of Systematic Reviews

SN - 1469-493X

IS - 9

ER -